From: Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts
Cell line | Doubling time (h) | IC50 (ng/ml) |
---|---|---|
RT112 | 23.28 ± 2.88 | 1.63 ± 0.55 |
RT112rGEMCI20 | 25.2 ± 3.12 | 125.40 ± 29.78 |
RT112luc | 24.72 ± 5.04 | 1.94 ± 0.24 |
RT112rGEMCI20luc | 27.36 ± 3.6 | 114.39 ± 14.52 |